NFATC2 in pancreatic cancer-associated fibroblasts predicts treatment response and facilitates ERBB-targeted therapies
JIAHAO GUO, Samuele Cancellieri, Chi Xu…·Biswajyoti Sahu
The paper identifies NFATC2-expressing cancer-associated fibroblasts in PDAC that improve treatment response and enhance ERBB-targeted therapies.